Events & Implementation Activities
Where personalised medicine moves from discussion to delivery.
IPM Alliance convenes political, scientific, clinical, patient, industry and health-system stakeholders to address the practical barriers that prevent personalised medicine from reaching patients.
Across political sessions, implementation labs, congress-side meetings, expert roundtables and business-facing innovation meetings, our events are designed to produce more than discussion. They create policy signals, implementation briefs, pathway prototypes, stakeholder takeaways, readiness maps and follow-up workstreams.
Events
Featured upcoming activities
Explore upcoming IPM Alliance events and implementation activities across global policy, regional engagement, scientific congresses and business-facing innovation settings.
ASCO Oncology Pillar Launch
A high-level ASCO-side launch session introducing the Oncology Pillar of the International Alliance for Personalised Medicine. The session will bring together oncology leaders, clinical innovators, policymakers, payers, HTA and regulatory experts, diagnostics and data partners, patient voices and industry leaders to discuss how precision oncology can move from breakthrough science to routine, equitable real-world delivery.
Expected output:
Oncology Pillar launch, Leadership Circle, founding stakeholder alignment and 12-month roadmap.
JPM Week Investability Lab
A business and innovation-facing implementation lab during J.P. Morgan Week, focused on turning precision medicine innovation into scalable patient access.
Expected output:
Five prototypes, investability map, Top 10 last-mile investment gaps and 90-day partner validation plan.
Dublin Presidency Policy Forum
A cross-disease European policy forum during Ireland’s 2026 EU Presidency, focused on moving AI-enabled diagnostics from pilots into trusted routine care.
Expected output:
Dublin Statement, five to seven priorities, AI diagnostic pathway map and follow-up policy communiqué.
UNGA Political Implementation Lab
A high-level UNGA week lab focused on fixing the last mile of personalised medicine through earlier diagnosis, targeted treatment and access.
Expected output:
Political Statement, four implementation prototypes, 90-day validation plan and 12-month roadmap.
ESMO Precision Oncology Session
A focused global discussion alongside ESMO on the access barriers that determine whether precision oncology reaches patients.
Expected output:
Global access statement, five to seven implementation priorities, eligibility-to-access pathway map and policy communiqué.